Application Nr Approved Date Route Status External Links
NDA019386 None Intravenous None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications & Usage 1.1 Supraventricular Tachycardia Or Noncompensatory Sinus Tachycardia Brevibloc (Esmolol Hydrochloride) Injection Is Indicated For The Rapid Control Of Ventricular Rate In Patients With Atrial Fibrillation Or Atrial Flutter In Perioperative, Postoperative, Or Other Emergent Circumstances Where Short Term Control Of Ventricular Rate With A Short-Acting Agent Is Desirable. Brevibloc Injection Is Also Indicated In Noncompensatory Sinus Tachycardia Where, In The Physician’s Judgment, The Rapid Heart Rate Requires Specific Intervention. Brevibloc Injection Is Intended For Short-Term Use. 1.2 Intraoperative And Postoperative Tachycardia And/or Hypertension Brevibloc (Esmolol Hydrochloride) Injection Is Indicated For The Short-Term Treatment Of Tachycardia And Hypertension That Occur During Induction And Tracheal Intubation, During Surgery, On Emergence From Anesthesia And In The Postoperative Period, When In The Physician’s Judgment Such Specific Intervention Is Considered Indicated. Use Of Brevibloc Injection To Prevent Such Events Is Not Recommended.

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Esmolol Hydrochloride ESMOLOL HYDROCHLORIDE ZINC896523

Comments